<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-pharmaceutics-12-00171">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sagar</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Pilakka-Kanthikeel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pottathil</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Saxena</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Nair</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Towards nanomedicines for neuroAIDS: Nanomedicines for neuroAIDS</article-title>
  <source>Rev. Med. Virol.</source>
  <year>2014</year>
  <volume>24</volume>
  <fpage>103</fpage>
  <lpage>124</lpage>
  <pub-id pub-id-type="doi">10.1002/rmv.1778</pub-id>
  <pub-id pub-id-type="pmid">24395761</pub-id>
 </element-citation>
</ref>
